Adma Biologics (ADMA) Return on Equity [ROE] (2011 - 2026)
Adma Biologics (ADMA) reported Return on Equity [ROE] of 42.32% for Q2 2026, down 11.83 percentage points from 54.14% a year earlier but up 4.20 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Adma Biologics posted Return on Equity [ROE] of 35.56%, down 46.08 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +169.45 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 81.65% in FY2024 (+101.31 pp), -19.67% in FY2023 (+25.30 pp), -44.96% in FY2022 (+17.28 pp) and -62.24% in FY2021 (+71.65 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -70.16% in Q3 2021 and a high of 68.06% in Q4 2024.
- Year over year, Return on Equity [ROE] has now declined in each of the last three quarters, with an average year-over-year change of +22.52 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 87.76 percentage points); the low point was Q4 2025 (a drop of 35.71 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 38.12% (Q1 2026), 32.35% (Q4 2025) and 50.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Adma Biologics | 2.26 Bn | 1.84 Bn | 86.28 Mn | 42.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.32% |
| Mar 31, 2026 | 38.12% |
| Dec 31, 2025 | 32.35% |
| Sep 30, 2025 | 50.50% |
| Jun 30, 2025 | 54.14% |
| Mar 31, 2025 | 57.24% |
| Dec 31, 2024 | 68.06% |
| Sep 30, 2024 | 32.43% |
| Jun 30, 2024 | 20.35% |
| Mar 31, 2024 | -2.52% |
| Dec 31, 2023 | -19.70% |
| Sep 30, 2023 | -15.02% |
| Jun 30, 2023 | -27.25% |
| Mar 31, 2023 | -31.73% |
| Dec 31, 2022 | -46.44% |
| Sep 30, 2022 | -58.95% |
| Jun 30, 2022 | -54.82% |
| Mar 31, 2022 | -53.14% |
| Dec 31, 2021 | -58.53% |
| Sep 30, 2021 | -70.16% |
API Access
Adma Biologics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();